{SNA} Apoptosis and Cell Cycle, Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Mitochondrial Proteins, Antibodies, and Transport Inhibitors, Mitochondrial Transport Inhibitors, Pfizer Compounds
Apoptosis and Cell Cycle, Approved Therapeutics/Drug Candidates, Cell Biology, Cell Signaling and Neuroscience, Mitochondrial Proteins, Antibodies, and Transport Inhibitors, Mitochondrial Transport Inhibitors, Pfizer Compounds
{SNA} Apoptosis and Cell Cycle, Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Mitochondrial Proteins, Antibodies, and Transport Inhibitors, Mitochondrial Transport Inhibitors, Pfizer Compounds, U, 生物活性小分子,
相关文献及参考
[2]. Wiemer EA, et al. The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications. Biochem J. 1995 Dec 1;312 ( Pt 2):479-84.
[3]. Hinoi E, et al. A molecular mechanism of pyruvate protection against cytotoxicity of reactive oxygen species in osteoblasts. Mol Pharmacol. 2006 Sep;70(3):925-35. Epub 2006 Jun 9.
[4]. Patterson JN, et al. Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated secretion. J Biol Chem. 2014 May 9;289(19):13335-46.
[5]. Zhong Y, et al. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro. Oncotarget. 2015 Nov 10;6(35):37758-69.
Butcher, L., et al., Metabolism of pyruvate by the early human embryo. Biol. Reprod. 58 , 1054-1056, (1998)
Nakamichi, N., et al., Protection by exogenous pyruvate thro